nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—CHRM3—epilepsy syndrome	0.182	0.34	CbGaD
Scopolamine—CHRM1—epilepsy syndrome	0.169	0.317	CbGaD
Scopolamine—CHRM2—epilepsy syndrome	0.138	0.259	CbGaD
Scopolamine—ABCB1—epilepsy syndrome	0.0452	0.0846	CbGaD
Scopolamine—ABCB1—Levetiracetam—epilepsy syndrome	0.0341	0.208	CbGbCtD
Scopolamine—ABCB1—Clobazam—epilepsy syndrome	0.0237	0.144	CbGbCtD
Scopolamine—ABCB1—Lamotrigine—epilepsy syndrome	0.0228	0.139	CbGbCtD
Scopolamine—ABCB1—Carbamazepine—epilepsy syndrome	0.0196	0.12	CbGbCtD
Scopolamine—ABCB1—Phenytoin—epilepsy syndrome	0.0176	0.107	CbGbCtD
Scopolamine—ABCB1—Phenobarbital—epilepsy syndrome	0.0157	0.0957	CbGbCtD
Scopolamine—ABCB1—Midazolam—epilepsy syndrome	0.0155	0.0944	CbGbCtD
Scopolamine—ABCB1—Diazepam—epilepsy syndrome	0.0149	0.0907	CbGbCtD
Scopolamine—SI—head—epilepsy syndrome	0.00132	0.0787	CbGeAlD
Scopolamine—SI—nervous system—epilepsy syndrome	0.00125	0.0746	CbGeAlD
Scopolamine—SI—central nervous system—epilepsy syndrome	0.00121	0.0718	CbGeAlD
Scopolamine—SI—brain—epilepsy syndrome	0.000957	0.057	CbGeAlD
Scopolamine—CHRM4—head—epilepsy syndrome	0.000652	0.0389	CbGeAlD
Scopolamine—CHRM4—nervous system—epilepsy syndrome	0.000618	0.0369	CbGeAlD
Scopolamine—CHRM2—forebrain—epilepsy syndrome	0.000611	0.0364	CbGeAlD
Scopolamine—CHRM4—central nervous system—epilepsy syndrome	0.000595	0.0355	CbGeAlD
Scopolamine—CHRM2—telencephalon—epilepsy syndrome	0.000562	0.0335	CbGeAlD
Scopolamine—CHRM1—forebrain—epilepsy syndrome	0.000556	0.0332	CbGeAlD
Scopolamine—CHRM1—telencephalon—epilepsy syndrome	0.000511	0.0305	CbGeAlD
Scopolamine—CHRM5—head—epilepsy syndrome	0.00051	0.0304	CbGeAlD
Scopolamine—CHRM3—forebrain—epilepsy syndrome	0.000498	0.0297	CbGeAlD
Scopolamine—CHRM5—nervous system—epilepsy syndrome	0.000483	0.0288	CbGeAlD
Scopolamine—CHRM4—brain—epilepsy syndrome	0.000473	0.0282	CbGeAlD
Scopolamine—Methylscopolamine bromide—CHRM3—epilepsy syndrome	0.000466	0.0946	CrCbGaD
Scopolamine—CHRM5—central nervous system—epilepsy syndrome	0.000465	0.0277	CbGeAlD
Scopolamine—CHRM3—telencephalon—epilepsy syndrome	0.000458	0.0273	CbGeAlD
Scopolamine—Methylscopolamine bromide—CHRM1—epilepsy syndrome	0.000434	0.0882	CrCbGaD
Scopolamine—CHRM5—brain—epilepsy syndrome	0.000369	0.022	CbGeAlD
Scopolamine—Hyoscyamine—CHRM3—epilepsy syndrome	0.000364	0.0739	CrCbGaD
Scopolamine—Methylscopolamine bromide—CHRM2—epilepsy syndrome	0.000355	0.0721	CrCbGaD
Scopolamine—CHRM2—head—epilepsy syndrome	0.00035	0.0209	CbGeAlD
Scopolamine—Homatropine Methylbromide—CHRM3—epilepsy syndrome	0.000343	0.0698	CrCbGaD
Scopolamine—Hyoscyamine—CHRM1—epilepsy syndrome	0.000339	0.0689	CrCbGaD
Scopolamine—CHRM2—nervous system—epilepsy syndrome	0.000332	0.0198	CbGeAlD
Scopolamine—Homatropine Methylbromide—CHRM1—epilepsy syndrome	0.00032	0.0651	CrCbGaD
Scopolamine—CHRM2—central nervous system—epilepsy syndrome	0.000319	0.019	CbGeAlD
Scopolamine—CHRM1—head—epilepsy syndrome	0.000318	0.019	CbGeAlD
Scopolamine—Atropine—CHRM3—epilepsy syndrome	0.000309	0.0628	CrCbGaD
Scopolamine—Ipratropium bromide—CHRM3—epilepsy syndrome	0.000306	0.0622	CrCbGaD
Scopolamine—CHRM1—nervous system—epilepsy syndrome	0.000302	0.018	CbGeAlD
Scopolamine—CHRM1—central nervous system—epilepsy syndrome	0.000291	0.0173	CbGeAlD
Scopolamine—Atropine—CHRM1—epilepsy syndrome	0.000288	0.0586	CrCbGaD
Scopolamine—Ipratropium bromide—CHRM1—epilepsy syndrome	0.000285	0.058	CrCbGaD
Scopolamine—CHRM3—head—epilepsy syndrome	0.000285	0.017	CbGeAlD
Scopolamine—Hyoscyamine—CHRM2—epilepsy syndrome	0.000277	0.0563	CrCbGaD
Scopolamine—CHRM3—nervous system—epilepsy syndrome	0.00027	0.0161	CbGeAlD
Scopolamine—Homatropine Methylbromide—CHRM2—epilepsy syndrome	0.000261	0.0531	CrCbGaD
Scopolamine—CHRM3—central nervous system—epilepsy syndrome	0.00026	0.0155	CbGeAlD
Scopolamine—CHRM2—brain—epilepsy syndrome	0.000254	0.0151	CbGeAlD
Scopolamine—Atropine—CHRM2—epilepsy syndrome	0.000235	0.0478	CrCbGaD
Scopolamine—Ipratropium bromide—CHRM2—epilepsy syndrome	0.000233	0.0473	CrCbGaD
Scopolamine—CHRM1—brain—epilepsy syndrome	0.000231	0.0138	CbGeAlD
Scopolamine—CHRM3—brain—epilepsy syndrome	0.000207	0.0123	CbGeAlD
Scopolamine—ABCB1—forebrain—epilepsy syndrome	0.000194	0.0115	CbGeAlD
Scopolamine—ABCB1—telencephalon—epilepsy syndrome	0.000178	0.0106	CbGeAlD
Scopolamine—ABCB1—medulla oblongata—epilepsy syndrome	0.00014	0.00834	CbGeAlD
Scopolamine—ABCB1—midbrain—epilepsy syndrome	0.000128	0.00762	CbGeAlD
Scopolamine—ABCB1—spinal cord—epilepsy syndrome	0.000125	0.00744	CbGeAlD
Scopolamine—ABCB1—head—epilepsy syndrome	0.000111	0.00661	CbGeAlD
Scopolamine—Ipratropium bromide—CYP2D6—epilepsy syndrome	0.000107	0.0217	CrCbGaD
Scopolamine—ABCB1—nervous system—epilepsy syndrome	0.000105	0.00626	CbGeAlD
Scopolamine—ABCB1—central nervous system—epilepsy syndrome	0.000101	0.00603	CbGeAlD
Scopolamine—ABCB1—cerebellum—epilepsy syndrome	9.89e-05	0.0059	CbGeAlD
Scopolamine—Arrhythmia—Pregabalin—epilepsy syndrome	9.28e-05	0.000508	CcSEcCtD
Scopolamine—Headache—Acetazolamide—epilepsy syndrome	9.25e-05	0.000506	CcSEcCtD
Scopolamine—Feeling abnormal—Clonazepam—epilepsy syndrome	9.24e-05	0.000505	CcSEcCtD
Scopolamine—Abdominal pain—Zonisamide—epilepsy syndrome	9.19e-05	0.000503	CcSEcCtD
Scopolamine—Body temperature increased—Zonisamide—epilepsy syndrome	9.19e-05	0.000503	CcSEcCtD
Scopolamine—Agitation—Valproic Acid—epilepsy syndrome	9.19e-05	0.000503	CcSEcCtD
Scopolamine—Asthenia—Fosphenytoin—epilepsy syndrome	9.18e-05	0.000502	CcSEcCtD
Scopolamine—Visual impairment—Gabapentin—epilepsy syndrome	9.18e-05	0.000502	CcSEcCtD
Scopolamine—Feeling abnormal—Phenytoin—epilepsy syndrome	9.17e-05	0.000502	CcSEcCtD
Scopolamine—Fatigue—Carbamazepine—epilepsy syndrome	9.16e-05	0.000501	CcSEcCtD
Scopolamine—Somnolence—Lamotrigine—epilepsy syndrome	9.13e-05	0.0005	CcSEcCtD
Scopolamine—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	9.12e-05	0.000499	CcSEcCtD
Scopolamine—Mental disorder—Pregabalin—epilepsy syndrome	9.1e-05	0.000498	CcSEcCtD
Scopolamine—Pain—Carbamazepine—epilepsy syndrome	9.09e-05	0.000497	CcSEcCtD
Scopolamine—Constipation—Carbamazepine—epilepsy syndrome	9.09e-05	0.000497	CcSEcCtD
Scopolamine—Dizziness—Propofol—epilepsy syndrome	9.07e-05	0.000496	CcSEcCtD
Scopolamine—Pruritus—Fosphenytoin—epilepsy syndrome	9.05e-05	0.000495	CcSEcCtD
Scopolamine—Vertigo—Valproic Acid—epilepsy syndrome	8.98e-05	0.000492	CcSEcCtD
Scopolamine—Asthenia—Vigabatrin—epilepsy syndrome	8.94e-05	0.000489	CcSEcCtD
Scopolamine—Eye disorder—Gabapentin—epilepsy syndrome	8.9e-05	0.000487	CcSEcCtD
Scopolamine—Dizziness—Midazolam—epilepsy syndrome	8.87e-05	0.000486	CcSEcCtD
Scopolamine—Abdominal pain—Clonazepam—epilepsy syndrome	8.86e-05	0.000485	CcSEcCtD
Scopolamine—Body temperature increased—Clonazepam—epilepsy syndrome	8.86e-05	0.000485	CcSEcCtD
Scopolamine—Fatigue—Lamotrigine—epilepsy syndrome	8.85e-05	0.000484	CcSEcCtD
Scopolamine—Pruritus—Vigabatrin—epilepsy syndrome	8.82e-05	0.000483	CcSEcCtD
Scopolamine—Asthenia—Diazepam—epilepsy syndrome	8.81e-05	0.000482	CcSEcCtD
Scopolamine—Body temperature increased—Phenytoin—epilepsy syndrome	8.8e-05	0.000481	CcSEcCtD
Scopolamine—Pain—Lamotrigine—epilepsy syndrome	8.78e-05	0.00048	CcSEcCtD
Scopolamine—Constipation—Lamotrigine—epilepsy syndrome	8.78e-05	0.00048	CcSEcCtD
Scopolamine—Nausea—Acetazolamide—epilepsy syndrome	8.77e-05	0.00048	CcSEcCtD
Scopolamine—Dizziness—Levetiracetam—epilepsy syndrome	8.76e-05	0.000479	CcSEcCtD
Scopolamine—Feeling abnormal—Carbamazepine—epilepsy syndrome	8.76e-05	0.000479	CcSEcCtD
Scopolamine—Abdominal pain—Oxcarbazepine—epilepsy syndrome	8.75e-05	0.000479	CcSEcCtD
Scopolamine—Body temperature increased—Oxcarbazepine—epilepsy syndrome	8.75e-05	0.000479	CcSEcCtD
Scopolamine—Vomiting—Propofol—epilepsy syndrome	8.72e-05	0.000477	CcSEcCtD
Scopolamine—Pruritus—Diazepam—epilepsy syndrome	8.68e-05	0.000475	CcSEcCtD
Scopolamine—Conjunctivitis—Topiramate—epilepsy syndrome	8.67e-05	0.000475	CcSEcCtD
Scopolamine—Rash—Propofol—epilepsy syndrome	8.65e-05	0.000473	CcSEcCtD
Scopolamine—Dermatitis—Propofol—epilepsy syndrome	8.64e-05	0.000473	CcSEcCtD
Scopolamine—Headache—Propofol—epilepsy syndrome	8.59e-05	0.00047	CcSEcCtD
Scopolamine—Vomiting—Midazolam—epilepsy syndrome	8.53e-05	0.000467	CcSEcCtD
Scopolamine—Asthenia—Felbamate—epilepsy syndrome	8.52e-05	0.000466	CcSEcCtD
Scopolamine—Vision blurred—Pregabalin—epilepsy syndrome	8.52e-05	0.000466	CcSEcCtD
Scopolamine—Tremor—Pregabalin—epilepsy syndrome	8.47e-05	0.000463	CcSEcCtD
Scopolamine—Feeling abnormal—Lamotrigine—epilepsy syndrome	8.46e-05	0.000463	CcSEcCtD
Scopolamine—Rash—Midazolam—epilepsy syndrome	8.46e-05	0.000463	CcSEcCtD
Scopolamine—Dizziness—Fosphenytoin—epilepsy syndrome	8.46e-05	0.000463	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	8.45e-05	0.000463	CcSEcCtD
Scopolamine—Dermatitis—Midazolam—epilepsy syndrome	8.45e-05	0.000463	CcSEcCtD
Scopolamine—Vomiting—Levetiracetam—epilepsy syndrome	8.43e-05	0.000461	CcSEcCtD
Scopolamine—Headache—Midazolam—epilepsy syndrome	8.41e-05	0.00046	CcSEcCtD
Scopolamine—Pruritus—Felbamate—epilepsy syndrome	8.4e-05	0.00046	CcSEcCtD
Scopolamine—Abdominal pain—Carbamazepine—epilepsy syndrome	8.4e-05	0.00046	CcSEcCtD
Scopolamine—Body temperature increased—Carbamazepine—epilepsy syndrome	8.4e-05	0.00046	CcSEcCtD
Scopolamine—Rash—Levetiracetam—epilepsy syndrome	8.36e-05	0.000457	CcSEcCtD
Scopolamine—Dermatitis—Levetiracetam—epilepsy syndrome	8.35e-05	0.000457	CcSEcCtD
Scopolamine—Asthenia—Zonisamide—epilepsy syndrome	8.34e-05	0.000456	CcSEcCtD
Scopolamine—Mental disorder—Gabapentin—epilepsy syndrome	8.34e-05	0.000456	CcSEcCtD
Scopolamine—Dry mouth—Valproic Acid—epilepsy syndrome	8.33e-05	0.000456	CcSEcCtD
Scopolamine—Agitation—Pregabalin—epilepsy syndrome	8.31e-05	0.000455	CcSEcCtD
Scopolamine—Headache—Levetiracetam—epilepsy syndrome	8.3e-05	0.000454	CcSEcCtD
Scopolamine—Erythema—Gabapentin—epilepsy syndrome	8.29e-05	0.000454	CcSEcCtD
Scopolamine—Dizziness—Vigabatrin—epilepsy syndrome	8.24e-05	0.000451	CcSEcCtD
Scopolamine—Confusional state—Valproic Acid—epilepsy syndrome	8.23e-05	0.00045	CcSEcCtD
Scopolamine—Pruritus—Zonisamide—epilepsy syndrome	8.23e-05	0.00045	CcSEcCtD
Scopolamine—Oedema—Valproic Acid—epilepsy syndrome	8.16e-05	0.000446	CcSEcCtD
Scopolamine—Bradycardia—Topiramate—epilepsy syndrome	8.16e-05	0.000446	CcSEcCtD
Scopolamine—Nausea—Propofol—epilepsy syndrome	8.15e-05	0.000446	CcSEcCtD
Scopolamine—Vomiting—Fosphenytoin—epilepsy syndrome	8.13e-05	0.000445	CcSEcCtD
Scopolamine—Vertigo—Pregabalin—epilepsy syndrome	8.12e-05	0.000444	CcSEcCtD
Scopolamine—Abdominal pain—Lamotrigine—epilepsy syndrome	8.12e-05	0.000444	CcSEcCtD
Scopolamine—Body temperature increased—Lamotrigine—epilepsy syndrome	8.12e-05	0.000444	CcSEcCtD
Scopolamine—Dizziness—Diazepam—epilepsy syndrome	8.12e-05	0.000444	CcSEcCtD
Scopolamine—Rash—Fosphenytoin—epilepsy syndrome	8.06e-05	0.000441	CcSEcCtD
Scopolamine—Dermatitis—Fosphenytoin—epilepsy syndrome	8.06e-05	0.000441	CcSEcCtD
Scopolamine—Asthenia—Clonazepam—epilepsy syndrome	8.04e-05	0.00044	CcSEcCtD
Scopolamine—ABCB1—brain—epilepsy syndrome	8.03e-05	0.00479	CbGeAlD
Scopolamine—Headache—Fosphenytoin—epilepsy syndrome	8.01e-05	0.000438	CcSEcCtD
Scopolamine—Nervous system disorder—Valproic Acid—epilepsy syndrome	8e-05	0.000438	CcSEcCtD
Scopolamine—Asthenia—Phenytoin—epilepsy syndrome	7.99e-05	0.000437	CcSEcCtD
Scopolamine—Nausea—Midazolam—epilepsy syndrome	7.97e-05	0.000436	CcSEcCtD
Scopolamine—Hallucination—Topiramate—epilepsy syndrome	7.97e-05	0.000436	CcSEcCtD
Scopolamine—Tachycardia—Valproic Acid—epilepsy syndrome	7.96e-05	0.000436	CcSEcCtD
Scopolamine—Pharyngitis—Topiramate—epilepsy syndrome	7.95e-05	0.000435	CcSEcCtD
Scopolamine—Asthenia—Oxcarbazepine—epilepsy syndrome	7.94e-05	0.000435	CcSEcCtD
Scopolamine—Pruritus—Clonazepam—epilepsy syndrome	7.93e-05	0.000434	CcSEcCtD
Scopolamine—Vomiting—Vigabatrin—epilepsy syndrome	7.93e-05	0.000434	CcSEcCtD
Scopolamine—Skin disorder—Valproic Acid—epilepsy syndrome	7.93e-05	0.000434	CcSEcCtD
Scopolamine—Urinary tract disorder—Topiramate—epilepsy syndrome	7.91e-05	0.000433	CcSEcCtD
Scopolamine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	7.89e-05	0.000432	CcSEcCtD
Scopolamine—Pruritus—Phenytoin—epilepsy syndrome	7.88e-05	0.000431	CcSEcCtD
Scopolamine—Nausea—Levetiracetam—epilepsy syndrome	7.87e-05	0.000431	CcSEcCtD
Scopolamine—Rash—Vigabatrin—epilepsy syndrome	7.86e-05	0.00043	CcSEcCtD
Scopolamine—Dizziness—Felbamate—epilepsy syndrome	7.86e-05	0.00043	CcSEcCtD
Scopolamine—Dermatitis—Vigabatrin—epilepsy syndrome	7.85e-05	0.00043	CcSEcCtD
Scopolamine—Urethral disorder—Topiramate—epilepsy syndrome	7.85e-05	0.00043	CcSEcCtD
Scopolamine—Pruritus—Oxcarbazepine—epilepsy syndrome	7.83e-05	0.000429	CcSEcCtD
Scopolamine—Vision blurred—Gabapentin—epilepsy syndrome	7.81e-05	0.000427	CcSEcCtD
Scopolamine—Headache—Vigabatrin—epilepsy syndrome	7.81e-05	0.000427	CcSEcCtD
Scopolamine—Vomiting—Diazepam—epilepsy syndrome	7.8e-05	0.000427	CcSEcCtD
Scopolamine—Tremor—Gabapentin—epilepsy syndrome	7.77e-05	0.000425	CcSEcCtD
Scopolamine—Rash—Diazepam—epilepsy syndrome	7.74e-05	0.000423	CcSEcCtD
Scopolamine—Dermatitis—Diazepam—epilepsy syndrome	7.73e-05	0.000423	CcSEcCtD
Scopolamine—Visual impairment—Topiramate—epilepsy syndrome	7.72e-05	0.000422	CcSEcCtD
Scopolamine—Dizziness—Zonisamide—epilepsy syndrome	7.69e-05	0.000421	CcSEcCtD
Scopolamine—Headache—Diazepam—epilepsy syndrome	7.69e-05	0.000421	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	7.64e-05	0.000418	CcSEcCtD
Scopolamine—Hypotension—Valproic Acid—epilepsy syndrome	7.63e-05	0.000417	CcSEcCtD
Scopolamine—Asthenia—Carbamazepine—epilepsy syndrome	7.62e-05	0.000417	CcSEcCtD
Scopolamine—Agitation—Gabapentin—epilepsy syndrome	7.62e-05	0.000417	CcSEcCtD
Scopolamine—Nausea—Fosphenytoin—epilepsy syndrome	7.6e-05	0.000416	CcSEcCtD
Scopolamine—Vomiting—Felbamate—epilepsy syndrome	7.55e-05	0.000413	CcSEcCtD
Scopolamine—Dry mouth—Pregabalin—epilepsy syndrome	7.53e-05	0.000412	CcSEcCtD
Scopolamine—Pruritus—Carbamazepine—epilepsy syndrome	7.52e-05	0.000411	CcSEcCtD
Scopolamine—Rash—Felbamate—epilepsy syndrome	7.49e-05	0.00041	CcSEcCtD
Scopolamine—Eye disorder—Topiramate—epilepsy syndrome	7.49e-05	0.00041	CcSEcCtD
Scopolamine—Dermatitis—Felbamate—epilepsy syndrome	7.48e-05	0.000409	CcSEcCtD
Scopolamine—Vertigo—Gabapentin—epilepsy syndrome	7.45e-05	0.000407	CcSEcCtD
Scopolamine—Headache—Felbamate—epilepsy syndrome	7.44e-05	0.000407	CcSEcCtD
Scopolamine—Confusional state—Pregabalin—epilepsy syndrome	7.44e-05	0.000407	CcSEcCtD
Scopolamine—Flushing—Topiramate—epilepsy syndrome	7.43e-05	0.000407	CcSEcCtD
Scopolamine—Dizziness—Clonazepam—epilepsy syndrome	7.41e-05	0.000405	CcSEcCtD
Scopolamine—Nausea—Vigabatrin—epilepsy syndrome	7.41e-05	0.000405	CcSEcCtD
Scopolamine—Vomiting—Zonisamide—epilepsy syndrome	7.39e-05	0.000405	CcSEcCtD
Scopolamine—Oedema—Pregabalin—epilepsy syndrome	7.38e-05	0.000404	CcSEcCtD
Scopolamine—Asthenia—Lamotrigine—epilepsy syndrome	7.37e-05	0.000403	CcSEcCtD
Scopolamine—Dizziness—Phenytoin—epilepsy syndrome	7.36e-05	0.000403	CcSEcCtD
Scopolamine—Rash—Zonisamide—epilepsy syndrome	7.33e-05	0.000401	CcSEcCtD
Scopolamine—Dermatitis—Zonisamide—epilepsy syndrome	7.32e-05	0.000401	CcSEcCtD
Scopolamine—Dizziness—Oxcarbazepine—epilepsy syndrome	7.32e-05	0.000401	CcSEcCtD
Scopolamine—Nausea—Diazepam—epilepsy syndrome	7.29e-05	0.000399	CcSEcCtD
Scopolamine—Headache—Zonisamide—epilepsy syndrome	7.28e-05	0.000399	CcSEcCtD
Scopolamine—Pruritus—Lamotrigine—epilepsy syndrome	7.27e-05	0.000398	CcSEcCtD
Scopolamine—Somnolence—Valproic Acid—epilepsy syndrome	7.25e-05	0.000397	CcSEcCtD
Scopolamine—Nervous system disorder—Pregabalin—epilepsy syndrome	7.23e-05	0.000396	CcSEcCtD
Scopolamine—Tachycardia—Pregabalin—epilepsy syndrome	7.2e-05	0.000394	CcSEcCtD
Scopolamine—Skin disorder—Pregabalin—epilepsy syndrome	7.17e-05	0.000392	CcSEcCtD
Scopolamine—Hyperhidrosis—Pregabalin—epilepsy syndrome	7.13e-05	0.00039	CcSEcCtD
Scopolamine—Vomiting—Clonazepam—epilepsy syndrome	7.13e-05	0.00039	CcSEcCtD
Scopolamine—Vomiting—Phenytoin—epilepsy syndrome	7.08e-05	0.000387	CcSEcCtD
Scopolamine—Rash—Clonazepam—epilepsy syndrome	7.07e-05	0.000387	CcSEcCtD
Scopolamine—Dermatitis—Clonazepam—epilepsy syndrome	7.06e-05	0.000386	CcSEcCtD
Scopolamine—Nausea—Felbamate—epilepsy syndrome	7.06e-05	0.000386	CcSEcCtD
Scopolamine—Vomiting—Oxcarbazepine—epilepsy syndrome	7.04e-05	0.000385	CcSEcCtD
Scopolamine—Fatigue—Valproic Acid—epilepsy syndrome	7.04e-05	0.000385	CcSEcCtD
Scopolamine—Dizziness—Carbamazepine—epilepsy syndrome	7.03e-05	0.000384	CcSEcCtD
Scopolamine—Headache—Clonazepam—epilepsy syndrome	7.02e-05	0.000384	CcSEcCtD
Scopolamine—Rash—Phenytoin—epilepsy syndrome	7.02e-05	0.000384	CcSEcCtD
Scopolamine—Mental disorder—Topiramate—epilepsy syndrome	7.02e-05	0.000384	CcSEcCtD
Scopolamine—Dermatitis—Phenytoin—epilepsy syndrome	7.01e-05	0.000384	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	7.01e-05	0.000383	CcSEcCtD
Scopolamine—Rash—Oxcarbazepine—epilepsy syndrome	6.98e-05	0.000382	CcSEcCtD
Scopolamine—Constipation—Valproic Acid—epilepsy syndrome	6.98e-05	0.000382	CcSEcCtD
Scopolamine—Pain—Valproic Acid—epilepsy syndrome	6.98e-05	0.000382	CcSEcCtD
Scopolamine—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.98e-05	0.000382	CcSEcCtD
Scopolamine—Headache—Phenytoin—epilepsy syndrome	6.97e-05	0.000382	CcSEcCtD
Scopolamine—Erythema—Topiramate—epilepsy syndrome	6.97e-05	0.000382	CcSEcCtD
Scopolamine—Headache—Oxcarbazepine—epilepsy syndrome	6.94e-05	0.00038	CcSEcCtD
Scopolamine—Nausea—Zonisamide—epilepsy syndrome	6.91e-05	0.000378	CcSEcCtD
Scopolamine—Dry mouth—Gabapentin—epilepsy syndrome	6.9e-05	0.000378	CcSEcCtD
Scopolamine—Hypotension—Pregabalin—epilepsy syndrome	6.89e-05	0.000377	CcSEcCtD
Scopolamine—Confusional state—Gabapentin—epilepsy syndrome	6.82e-05	0.000373	CcSEcCtD
Scopolamine—Dizziness—Lamotrigine—epilepsy syndrome	6.79e-05	0.000372	CcSEcCtD
Scopolamine—Oedema—Gabapentin—epilepsy syndrome	6.76e-05	0.00037	CcSEcCtD
Scopolamine—Vomiting—Carbamazepine—epilepsy syndrome	6.76e-05	0.00037	CcSEcCtD
Scopolamine—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.72e-05	0.000368	CcSEcCtD
Scopolamine—Rash—Carbamazepine—epilepsy syndrome	6.7e-05	0.000367	CcSEcCtD
Scopolamine—Dermatitis—Carbamazepine—epilepsy syndrome	6.69e-05	0.000366	CcSEcCtD
Scopolamine—Nausea—Clonazepam—epilepsy syndrome	6.66e-05	0.000364	CcSEcCtD
Scopolamine—Headache—Carbamazepine—epilepsy syndrome	6.66e-05	0.000364	CcSEcCtD
Scopolamine—Nervous system disorder—Gabapentin—epilepsy syndrome	6.63e-05	0.000363	CcSEcCtD
Scopolamine—Nausea—Phenytoin—epilepsy syndrome	6.61e-05	0.000362	CcSEcCtD
Scopolamine—Tachycardia—Gabapentin—epilepsy syndrome	6.6e-05	0.000361	CcSEcCtD
Scopolamine—Nausea—Oxcarbazepine—epilepsy syndrome	6.58e-05	0.00036	CcSEcCtD
Scopolamine—Vision blurred—Topiramate—epilepsy syndrome	6.57e-05	0.00036	CcSEcCtD
Scopolamine—Skin disorder—Gabapentin—epilepsy syndrome	6.57e-05	0.00036	CcSEcCtD
Scopolamine—Somnolence—Pregabalin—epilepsy syndrome	6.56e-05	0.000359	CcSEcCtD
Scopolamine—Hyperhidrosis—Gabapentin—epilepsy syndrome	6.54e-05	0.000358	CcSEcCtD
Scopolamine—Tremor—Topiramate—epilepsy syndrome	6.53e-05	0.000357	CcSEcCtD
Scopolamine—Vomiting—Lamotrigine—epilepsy syndrome	6.53e-05	0.000357	CcSEcCtD
Scopolamine—Rash—Lamotrigine—epilepsy syndrome	6.47e-05	0.000354	CcSEcCtD
Scopolamine—Dermatitis—Lamotrigine—epilepsy syndrome	6.47e-05	0.000354	CcSEcCtD
Scopolamine—Abdominal pain—Valproic Acid—epilepsy syndrome	6.45e-05	0.000353	CcSEcCtD
Scopolamine—Body temperature increased—Valproic Acid—epilepsy syndrome	6.45e-05	0.000353	CcSEcCtD
Scopolamine—Headache—Lamotrigine—epilepsy syndrome	6.43e-05	0.000352	CcSEcCtD
Scopolamine—Agitation—Topiramate—epilepsy syndrome	6.41e-05	0.000351	CcSEcCtD
Scopolamine—Fatigue—Pregabalin—epilepsy syndrome	6.36e-05	0.000348	CcSEcCtD
Scopolamine—Hypotension—Gabapentin—epilepsy syndrome	6.32e-05	0.000346	CcSEcCtD
Scopolamine—Nausea—Carbamazepine—epilepsy syndrome	6.31e-05	0.000345	CcSEcCtD
Scopolamine—Pain—Pregabalin—epilepsy syndrome	6.31e-05	0.000345	CcSEcCtD
Scopolamine—Constipation—Pregabalin—epilepsy syndrome	6.31e-05	0.000345	CcSEcCtD
Scopolamine—Vertigo—Topiramate—epilepsy syndrome	6.27e-05	0.000343	CcSEcCtD
Scopolamine—Nausea—Lamotrigine—epilepsy syndrome	6.1e-05	0.000334	CcSEcCtD
Scopolamine—Feeling abnormal—Pregabalin—epilepsy syndrome	6.08e-05	0.000333	CcSEcCtD
Scopolamine—Somnolence—Gabapentin—epilepsy syndrome	6.01e-05	0.000329	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.9e-05	0.000323	CcSEcCtD
Scopolamine—Asthenia—Valproic Acid—epilepsy syndrome	5.85e-05	0.00032	CcSEcCtD
Scopolamine—Fatigue—Gabapentin—epilepsy syndrome	5.83e-05	0.000319	CcSEcCtD
Scopolamine—Abdominal pain—Pregabalin—epilepsy syndrome	5.83e-05	0.000319	CcSEcCtD
Scopolamine—Body temperature increased—Pregabalin—epilepsy syndrome	5.83e-05	0.000319	CcSEcCtD
Scopolamine—Dry mouth—Topiramate—epilepsy syndrome	5.81e-05	0.000318	CcSEcCtD
Scopolamine—Pain—Gabapentin—epilepsy syndrome	5.78e-05	0.000317	CcSEcCtD
Scopolamine—Constipation—Gabapentin—epilepsy syndrome	5.78e-05	0.000317	CcSEcCtD
Scopolamine—Pruritus—Valproic Acid—epilepsy syndrome	5.77e-05	0.000316	CcSEcCtD
Scopolamine—Confusional state—Topiramate—epilepsy syndrome	5.74e-05	0.000314	CcSEcCtD
Scopolamine—Oedema—Topiramate—epilepsy syndrome	5.69e-05	0.000311	CcSEcCtD
Scopolamine—Nervous system disorder—Topiramate—epilepsy syndrome	5.58e-05	0.000305	CcSEcCtD
Scopolamine—Feeling abnormal—Gabapentin—epilepsy syndrome	5.57e-05	0.000305	CcSEcCtD
Scopolamine—Tachycardia—Topiramate—epilepsy syndrome	5.55e-05	0.000304	CcSEcCtD
Scopolamine—Skin disorder—Topiramate—epilepsy syndrome	5.53e-05	0.000302	CcSEcCtD
Scopolamine—Hyperhidrosis—Topiramate—epilepsy syndrome	5.5e-05	0.000301	CcSEcCtD
Scopolamine—Dizziness—Valproic Acid—epilepsy syndrome	5.4e-05	0.000295	CcSEcCtD
Scopolamine—Body temperature increased—Gabapentin—epilepsy syndrome	5.35e-05	0.000293	CcSEcCtD
Scopolamine—Abdominal pain—Gabapentin—epilepsy syndrome	5.35e-05	0.000293	CcSEcCtD
Scopolamine—Hypotension—Topiramate—epilepsy syndrome	5.32e-05	0.000291	CcSEcCtD
Scopolamine—Asthenia—Pregabalin—epilepsy syndrome	5.29e-05	0.00029	CcSEcCtD
Scopolamine—Pruritus—Pregabalin—epilepsy syndrome	5.22e-05	0.000286	CcSEcCtD
Scopolamine—Vomiting—Valproic Acid—epilepsy syndrome	5.19e-05	0.000284	CcSEcCtD
Scopolamine—Rash—Valproic Acid—epilepsy syndrome	5.15e-05	0.000282	CcSEcCtD
Scopolamine—Dermatitis—Valproic Acid—epilepsy syndrome	5.14e-05	0.000281	CcSEcCtD
Scopolamine—Headache—Valproic Acid—epilepsy syndrome	5.11e-05	0.00028	CcSEcCtD
Scopolamine—Somnolence—Topiramate—epilepsy syndrome	5.06e-05	0.000277	CcSEcCtD
Scopolamine—Fatigue—Topiramate—epilepsy syndrome	4.91e-05	0.000268	CcSEcCtD
Scopolamine—Dizziness—Pregabalin—epilepsy syndrome	4.88e-05	0.000267	CcSEcCtD
Scopolamine—Pain—Topiramate—epilepsy syndrome	4.87e-05	0.000266	CcSEcCtD
Scopolamine—Constipation—Topiramate—epilepsy syndrome	4.87e-05	0.000266	CcSEcCtD
Scopolamine—Asthenia—Gabapentin—epilepsy syndrome	4.85e-05	0.000266	CcSEcCtD
Scopolamine—Nausea—Valproic Acid—epilepsy syndrome	4.85e-05	0.000265	CcSEcCtD
Scopolamine—Pruritus—Gabapentin—epilepsy syndrome	4.79e-05	0.000262	CcSEcCtD
Scopolamine—Vomiting—Pregabalin—epilepsy syndrome	4.69e-05	0.000257	CcSEcCtD
Scopolamine—Feeling abnormal—Topiramate—epilepsy syndrome	4.69e-05	0.000257	CcSEcCtD
Scopolamine—Rash—Pregabalin—epilepsy syndrome	4.65e-05	0.000255	CcSEcCtD
Scopolamine—Dermatitis—Pregabalin—epilepsy syndrome	4.65e-05	0.000254	CcSEcCtD
Scopolamine—Headache—Pregabalin—epilepsy syndrome	4.62e-05	0.000253	CcSEcCtD
Scopolamine—Abdominal pain—Topiramate—epilepsy syndrome	4.5e-05	0.000246	CcSEcCtD
Scopolamine—Body temperature increased—Topiramate—epilepsy syndrome	4.5e-05	0.000246	CcSEcCtD
Scopolamine—Dizziness—Gabapentin—epilepsy syndrome	4.47e-05	0.000245	CcSEcCtD
Scopolamine—Nausea—Pregabalin—epilepsy syndrome	4.38e-05	0.00024	CcSEcCtD
Scopolamine—Vomiting—Gabapentin—epilepsy syndrome	4.3e-05	0.000235	CcSEcCtD
Scopolamine—Rash—Gabapentin—epilepsy syndrome	4.27e-05	0.000233	CcSEcCtD
Scopolamine—Dermatitis—Gabapentin—epilepsy syndrome	4.26e-05	0.000233	CcSEcCtD
Scopolamine—Headache—Gabapentin—epilepsy syndrome	4.24e-05	0.000232	CcSEcCtD
Scopolamine—Asthenia—Topiramate—epilepsy syndrome	4.08e-05	0.000223	CcSEcCtD
Scopolamine—Pruritus—Topiramate—epilepsy syndrome	4.03e-05	0.00022	CcSEcCtD
Scopolamine—Nausea—Gabapentin—epilepsy syndrome	4.02e-05	0.00022	CcSEcCtD
Scopolamine—Dizziness—Topiramate—epilepsy syndrome	3.76e-05	0.000206	CcSEcCtD
Scopolamine—Vomiting—Topiramate—epilepsy syndrome	3.62e-05	0.000198	CcSEcCtD
Scopolamine—Rash—Topiramate—epilepsy syndrome	3.59e-05	0.000196	CcSEcCtD
Scopolamine—Dermatitis—Topiramate—epilepsy syndrome	3.59e-05	0.000196	CcSEcCtD
Scopolamine—Headache—Topiramate—epilepsy syndrome	3.57e-05	0.000195	CcSEcCtD
Scopolamine—Nausea—Topiramate—epilepsy syndrome	3.38e-05	0.000185	CcSEcCtD
Scopolamine—CHRM4—Signaling Pathways—HES1—epilepsy syndrome	6.17e-06	6.35e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	6.12e-06	6.3e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—FYN—epilepsy syndrome	6e-06	6.18e-05	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.98e-06	6.16e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—H2AFX—epilepsy syndrome	5.98e-06	6.16e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MEF2C—epilepsy syndrome	5.97e-06	6.14e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	5.97e-06	6.14e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	5.97e-06	6.14e-05	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.96e-06	6.14e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	5.95e-06	6.13e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	5.95e-06	6.13e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HES1—epilepsy syndrome	5.91e-06	6.08e-05	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.9e-06	6.08e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	5.89e-06	6.07e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	5.89e-06	6.07e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	5.88e-06	6.05e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	5.86e-06	6.04e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	5.8e-06	5.98e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	5.8e-06	5.98e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SST—epilepsy syndrome	5.8e-06	5.98e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	5.8e-06	5.98e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	5.79e-06	5.96e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	5.79e-06	5.96e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SST—epilepsy syndrome	5.79e-06	5.96e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—YWHAZ—epilepsy syndrome	5.77e-06	5.94e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	5.75e-06	5.93e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—FYN—epilepsy syndrome	5.74e-06	5.92e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	5.73e-06	5.91e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	5.73e-06	5.9e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SST—epilepsy syndrome	5.73e-06	5.9e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	5.73e-06	5.9e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—H2AFX—epilepsy syndrome	5.72e-06	5.9e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MEF2C—epilepsy syndrome	5.71e-06	5.88e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NGF—epilepsy syndrome	5.7e-06	5.87e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	5.68e-06	5.85e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	5.68e-06	5.85e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	5.66e-06	5.83e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	5.66e-06	5.83e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	5.64e-06	5.81e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	5.61e-06	5.77e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	5.58e-06	5.75e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCR5—epilepsy syndrome	5.55e-06	5.71e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—YWHAZ—epilepsy syndrome	5.52e-06	5.69e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NGF—epilepsy syndrome	5.46e-06	5.62e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	5.46e-06	5.62e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	5.46e-06	5.62e-05	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	5.45e-06	5.61e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	5.44e-06	5.6e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	5.44e-06	5.6e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	5.43e-06	5.59e-05	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	5.43e-06	5.59e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HTR2A—epilepsy syndrome	5.43e-06	5.59e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	5.41e-06	5.58e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	5.41e-06	5.57e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	5.39e-06	5.55e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	5.39e-06	5.55e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	5.39e-06	5.55e-05	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	5.38e-06	5.54e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	5.36e-06	5.52e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	5.36e-06	5.52e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	5.36e-06	5.52e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	5.34e-06	5.5e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	5.34e-06	5.5e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	5.34e-06	5.5e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	5.34e-06	5.5e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	5.32e-06	5.48e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCR5—epilepsy syndrome	5.31e-06	5.47e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—HMOX1—epilepsy syndrome	5.29e-06	5.45e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	5.29e-06	5.45e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	5.29e-06	5.45e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	5.27e-06	5.43e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	5.23e-06	5.38e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CAT—epilepsy syndrome	5.22e-06	5.38e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	5.21e-06	5.37e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HTR2A—epilepsy syndrome	5.2e-06	5.35e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ABCG2—epilepsy syndrome	5.16e-06	5.32e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	5.16e-06	5.31e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TSC2—epilepsy syndrome	5.16e-06	5.31e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AGT—epilepsy syndrome	5.15e-06	5.3e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ABCB1—epilepsy syndrome	5.08e-06	5.23e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	5.07e-06	5.22e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	5.06e-06	5.21e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—APOE—epilepsy syndrome	5.05e-06	5.2e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	5.03e-06	5.18e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	5.01e-06	5.16e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	5e-06	5.15e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	4.98e-06	5.13e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	4.96e-06	5.11e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	4.95e-06	5.1e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—KDR—epilepsy syndrome	4.94e-06	5.09e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TSC2—epilepsy syndrome	4.94e-06	5.09e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	4.93e-06	5.08e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AGT—epilepsy syndrome	4.93e-06	5.08e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	4.92e-06	5.06e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	4.88e-06	5.03e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	4.86e-06	5.01e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	4.85e-06	4.99e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	4.84e-06	4.99e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—APOE—epilepsy syndrome	4.83e-06	4.98e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	4.83e-06	4.97e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	4.8e-06	4.94e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	4.78e-06	4.92e-05	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.77e-06	4.91e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PRKCB—epilepsy syndrome	4.76e-06	4.9e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6ST—epilepsy syndrome	4.74e-06	4.88e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—KDR—epilepsy syndrome	4.73e-06	4.88e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GPX1—epilepsy syndrome	4.72e-06	4.86e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	4.6e-06	4.74e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	4.58e-06	4.72e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PRKCB—epilepsy syndrome	4.56e-06	4.69e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	4.55e-06	4.69e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	4.54e-06	4.68e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	4.54e-06	4.68e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	4.54e-06	4.68e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6ST—epilepsy syndrome	4.54e-06	4.67e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	4.53e-06	4.66e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	4.51e-06	4.65e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	4.5e-06	4.63e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	4.48e-06	4.62e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	4.4e-06	4.53e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	4.38e-06	4.52e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	4.34e-06	4.47e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—POMC—epilepsy syndrome	4.33e-06	4.46e-05	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.3e-06	4.43e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	4.3e-06	4.42e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—BCHE—epilepsy syndrome	4.28e-06	4.41e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCL2—epilepsy syndrome	4.24e-06	4.37e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	4.16e-06	4.28e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—POMC—epilepsy syndrome	4.15e-06	4.28e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	4.15e-06	4.27e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AGT—epilepsy syndrome	4.14e-06	4.26e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	4.11e-06	4.23e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	4.08e-06	4.2e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCL2—epilepsy syndrome	4.06e-06	4.18e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APOE—epilepsy syndrome	4.06e-06	4.18e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	4.04e-06	4.17e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PLCB1—epilepsy syndrome	4.04e-06	4.16e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	4.03e-06	4.15e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	4.03e-06	4.15e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	4.02e-06	4.14e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—TH—epilepsy syndrome	4.02e-06	4.14e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	4.02e-06	4.14e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	4.01e-06	4.13e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	3.99e-06	4.11e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	3.98e-06	4.1e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	3.97e-06	4.09e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	3.89e-06	4e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	3.88e-06	3.99e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	3.84e-06	3.96e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.84e-06	3.95e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—FGF2—epilepsy syndrome	3.83e-06	3.95e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	3.83e-06	3.95e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	3.8e-06	3.91e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	3.74e-06	3.85e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	3.73e-06	3.84e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	3.69e-06	3.8e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—FGF2—epilepsy syndrome	3.67e-06	3.78e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	3.66e-06	3.77e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	3.65e-06	3.76e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	3.61e-06	3.72e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RELA—epilepsy syndrome	3.56e-06	3.67e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MTOR—epilepsy syndrome	3.49e-06	3.59e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—POMC—epilepsy syndrome	3.48e-06	3.59e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	3.48e-06	3.58e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	3.47e-06	3.58e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	3.47e-06	3.57e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	3.46e-06	3.57e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	3.43e-06	3.54e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	3.43e-06	3.53e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RELA—epilepsy syndrome	3.41e-06	3.51e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	3.4e-06	3.5e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	3.39e-06	3.49e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	3.36e-06	3.46e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	3.36e-06	3.46e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MTOR—epilepsy syndrome	3.34e-06	3.44e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	3.33e-06	3.43e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	3.32e-06	3.42e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CAT—epilepsy syndrome	3.31e-06	3.41e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	3.29e-06	3.39e-05	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AKT1—epilepsy syndrome	3.24e-06	3.34e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CASP3—epilepsy syndrome	3.21e-06	3.31e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	3.21e-06	3.3e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	3.2e-06	3.29e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	3.2e-06	3.29e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	3.19e-06	3.28e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ALB—epilepsy syndrome	3.18e-06	3.27e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	3.17e-06	3.26e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	3.15e-06	3.25e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—JUN—epilepsy syndrome	3.12e-06	3.21e-05	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	3.1e-06	3.2e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	3.07e-06	3.17e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	3.03e-06	3.12e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GPX1—epilepsy syndrome	3e-06	3.09e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	2.99e-06	3.07e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	2.94e-06	3.03e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	2.92e-06	3.01e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	2.91e-06	3e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	2.9e-06	2.99e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	2.89e-06	2.97e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	2.86e-06	2.95e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	2.85e-06	2.94e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	2.82e-06	2.91e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	2.82e-06	2.9e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	2.8e-06	2.88e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PTGS2—epilepsy syndrome	2.78e-06	2.86e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	2.72e-06	2.81e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	2.68e-06	2.76e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AGT—epilepsy syndrome	2.63e-06	2.71e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	2.61e-06	2.69e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	2.58e-06	2.66e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	2.58e-06	2.65e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOE—epilepsy syndrome	2.57e-06	2.65e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	2.55e-06	2.63e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	2.4e-06	2.47e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	2.39e-06	2.46e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	2.37e-06	2.44e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	2.35e-06	2.42e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	2.35e-06	2.42e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	2.32e-06	2.39e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—POMC—epilepsy syndrome	2.21e-06	2.28e-05	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.18e-06	2.25e-05	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.18e-06	2.24e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.16e-06	2.23e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	2.16e-06	2.22e-05	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.16e-06	2.22e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	2.14e-06	2.2e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	2.1e-06	2.17e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	2.1e-06	2.16e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	2.07e-06	2.14e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.05e-06	2.11e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	2.04e-06	2.1e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	2.02e-06	2.08e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ALB—epilepsy syndrome	2.02e-06	2.08e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.98e-06	2.04e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	1.98e-06	2.04e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.96e-06	2.02e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	1.89e-06	1.94e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	1.88e-06	1.94e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.86e-06	1.92e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.84e-06	1.89e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.83e-06	1.89e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.81e-06	1.87e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.76e-06	1.82e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	1.74e-06	1.79e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	1.66e-06	1.71e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.4e-06	1.44e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.17e-06	1.21e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.17e-06	1.2e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.16e-06	1.19e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AKT1—epilepsy syndrome	8.86e-07	9.13e-06	CbGpPWpGaD
